GlaxoSmithKline's (GSK.US) new oral antibiotic has been approved for the treatment of urinary tract infections in the UK.

According to the Securities Times app, recently, a oral antibiotic developed by GlaxoSmithKline (GSK.US) has been approved in the UK for the treatment of uncomplicated urinary tract infections. According to the British drug regulatory agency, about half of women in the country have been troubled by this disease.